Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transfusion chronic liver disease

R L Koretz, S C Suffin, G L Gitnick

    Gastroenterology
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Post-transfusion hepatitis can lead to chronic liver disease, even in hepatitis B surface antigen-negative recipients. Close patient follow-up and liver biopsy are crucial for prolonged transaminase elevations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Branched-chain amino acids for hepatic encephalopathy.

    The Cochrane database of systematic reviews·2003
    Same author

    Hepatitis C--the case against treatment.

    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·2001
    Same author

    Is there a place for placebos?

    Gastroenterology·2001
    Same author

    AGA technical review on parenteral nutrition.

    Gastroenterology·2001
    Same author

    What will you be when you grow up?

    Gastroenterology·2001
    Same author

    The road not taken.

    Gastroenterology·2001

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Transfusion Medicine

    Background:

    • Post-transfusion hepatitis is a significant concern following blood transfusions.
    • Understanding the long-term outcomes and risk factors for chronic hepatitis is essential.

    Purpose of the Study:

    • To document the sequelae of acute hepatitis in blood recipients.
    • To assess factors influencing the development of chronic hepatitis (CH).

    Main Methods:

    • Prospective follow-up of 47 patients with post-transfusion hepatitis.
    • Classification of chronic hepatitis based on prolonged serum glutamic pyruvic transaminase (T) elevations (>20 weeks).
    • Comparison of patients with CH versus acute hepatitis; liver biopsies performed on CH patients.

    Related Experiment Videos

    Main Results:

    • Twenty-nine patients (62%) developed chronic hepatitis (CH).
    • No significant differences were found between CH and acute hepatitis groups regarding demographic, transfusion, or clinical factors.
    • Liver biopsies revealed chronic-active hepatitis in 9/15 (60%) of CH patients, with 5 being asymptomatic.

    Conclusions:

    • Chronic liver disease frequently develops after acute post-transfusion hepatitis, particularly in multiply transfused, hepatitis B surface antigen-negative recipients.
    • Close follow-up, including liver biopsy, is warranted for patients with prolonged transaminase elevations post-transfusion.